名称 | AKT3 E17K/BaF3 |
型号 | CBP73280 |
报价 | ![]() |
特点 | AKT3 E17K/BaF3,母细胞:BaF3,AKT3 E17K 存在于 0.03% 的 AACR GENIE 病例中,其中皮肤黑色素瘤、间变性少突胶质细胞瘤、平滑肌肉瘤、前列腺腺癌和肢端黑色素瘤的患病率相对较高。 |
产品搜索
相关文章
联系我们
联系人:蒋经理
电话:86-25-86880024
号码:86-25-86880024
手机:18066071954
地址:南京市雨花区长虹路222号
Email: zhangxiangwen@cobioer.com
电话:86-25-86880024
号码:86-25-86880024
手机:18066071954
地址:南京市雨花区长虹路222号
Email: zhangxiangwen@cobioer.com
产品展示 / PRODUCTS
药靶细胞株 > kinase激酶细胞株 > CBP73280AKT3 E17K/BaF3

- 详细内容
CBP73280 | |
I. Introduction | |
Cell Line Name: | AKT3 E17K/BaF3 |
Host Cell: | Ba/F3 |
Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS |
Mycoplasma Status: | Negative |
II. Background | |
AKT3 E17K is present in 0.03% of AACR GENIE cases, with cutaneous melanoma, anaplastic oligodendroglioma, leiomyosarcoma, prostate adenocarcinoma, and acral lentiginous melanoma having the greatest prevalence. | |
III. Representative Data | |
1.WB of AKT3 E17K/BaF3 | |
2. Anti-proliferation assay | |
Figure 2. CTG Proliferation Assay of BaF3 AKT3 E17K Cells (C2). |